Fundamentals of MorphoSys Group

(in € million, if not stated otherwise)

 

12/31/2010

12/31/2009

12/31/2008

Results (IFRS)

Revenues

87.0

81.0

71.6

Cost of Goods Sold

7.3

6.7

7.1

R&D Expenses

46.9

39.0

27.6

S, G&A Expenses

23.2

23.9

20.5

Personnel Expenses (excluding Stock-based Compensation)

29.6

26.1

21.5

Capital Expenditure

13.8

3.8

3.8

Depreciation

2.1

1.6

1.5

Amortization of Intangible Assets

4.0

3.8

3.7

Profit from Operations

9.8

11.4

16.4

EBITDA (Earnings before Interest,
Taxes, Depreciation and Amortization)

19.2

18.1

21.9

EBIT (Earnings before Interest and Taxes)

13.1

12.8

16.5

Net Profit

9.2

9.0

13.2

Balance Sheet (IFRS)

Total Assets

212.6

206.1

203.3

Cash, Cash Equivalents and Marketable Securities

108.4

135.1

137.9

Intangible Assets

69.2

17.4

19.7

Total Liabilities

26.6

32.2

41.3

Stockholders’ Equity

185.9

173.9

162.0

Equity Ratio (in %)

87 %

84 %

80 %

MorphoSys Share

Number of Shares Issued

22,890,251

22,660,557

22,478,787

Earnings per Share (diluted) (in €)

0.40

0.40

0.59

Dividend (in €)

Share Price (in €)

18.53

17.04

18.75

Average Daily Trading Volume

1.1

1.3

1.9

Personnel Data

Total Group Employees (Number)

464

404

334

In Germany (Number)

370

301

236

Other Countries (Number)

94

103

98